Combining the specific anti-MUC1 antibody TAB004 and LIP-MSA-IL-2 limits pancreatic cancer progression in immune competent murine models of pancreatic ductal adenocarcinoma

Combining the specific anti-MUC1 antibody TAB004 and LIP-MSA-IL-2 limits pancreatic cancer progression in immune competent murine models of pancreatic ductal adenocarcinoma

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journa...

Full description

Bibliographic Details
Main Authors: Dreau, Didier (Author), Moore, Laura Jeffords (Author), Wu, Mike (Author), Roy, Lopa Das (Author), Dillion, Lloye (Author), Porter, Travis (Author), Puri, Rahul (Author), Momin, Noor (Author), Wittrup, Karl Dane (Author), Mukherjee, Pinku (Author)
Other Authors: Koch Institute for Integrative Cancer Research at MIT (Contributor)
Format: Article
Language:English
Published: Frontiers Media SA, 2020-06-17T12:56:52Z.
Subjects:
Article
Online Access:Get fulltext

Similar Items

Similar Items